Role of mineralocorticoid receptors in arterial stiffness in human aging.
about
Acute effect of mineralocorticoid receptor antagonism on vascular function in healthy older adultsEplerenone for hypertension.Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension.Smooth Muscle Cell-Mineralocorticoid Receptor as a Mediator of Cardiovascular Stiffness With Aging.Add-On Use of Eplerenone Is Effective for Lowering Home and Ambulatory Blood Pressure in Drug-Resistant Hypertension.
P2860
Role of mineralocorticoid receptors in arterial stiffness in human aging.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Role of mineralocorticoid receptors in arterial stiffness in human aging.
@en
Role of mineralocorticoid receptors in arterial stiffness in human aging.
@nl
type
label
Role of mineralocorticoid receptors in arterial stiffness in human aging.
@en
Role of mineralocorticoid receptors in arterial stiffness in human aging.
@nl
prefLabel
Role of mineralocorticoid receptors in arterial stiffness in human aging.
@en
Role of mineralocorticoid receptors in arterial stiffness in human aging.
@nl
P2093
P2860
P1476
Role of mineralocorticoid receptors in arterial stiffness in human aging.
@en
P2093
Demetra D Christou
Han-Kyul Kim
Mark English
Meredith Luttrell
Moon-Hyon Hwang
Thomas H Meade
Wilmer W Nichols
P2860
P304
P356
10.1016/J.EXGER.2013.05.058
P50
P577
2013-05-23T00:00:00Z